Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Kets

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Medical Genetics|July 2, 2010
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriersR S van der Post, L A Kiemeney, M J L Ligtenberg, et al.
British Journal of Cancer|April 25, 2007
Patients with an unexplained microsatellite instable tumour have a low risk of familial cancerL I H Overbeek, C M Kets, K M Hebeda, et al.
Human Reproduction (Oxford, England)|January 12, 2017
Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partnersJ J G Gietel-Habets, C E M de Die-Smulders, I A P Derks-Smeets, et al.
British Journal of Cancer|November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeatsJ-F You, O Buhard, M J L Ligtenberg, et al.
Familial Cancer|June 20, 2024
Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case reportL van Riel, C M Kets, L P van Hest, et al.
Journal of Community Genetics|June 7, 2019
Genetic counseling of patients with ovarian carcinoma: acceptance, timing, and psychological wellbeingI Van de Beek, E M A Smets, M A Legdeur, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 8, 2012
Is colorectal surveillance indicated in patients with PTEN mutations?M H Nieuwenhuis, C M Kets, M Murphy-Ryan, et al.
Familial Cancer|January 5, 2019
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohortJ J Bakhuizen, F B Hogervorst, M E Velthuizen, et al.
Journal of the National Cancer Institute|March 20, 2015
Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reductionB A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, et al.
Clinical Genetics|January 17, 2013
MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype studyP Makrythanasis, B W van Bon, M Steehouwer, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medical Genetics|July 2, 2010
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriersR S van der Post, L A Kiemeney, M J L Ligtenberg, et al.
British Journal of Cancer|April 25, 2007
Patients with an unexplained microsatellite instable tumour have a low risk of familial cancerL I H Overbeek, C M Kets, K M Hebeda, et al.
Human Reproduction (Oxford, England)|January 12, 2017
Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partnersJ J G Gietel-Habets, C E M de Die-Smulders, I A P Derks-Smeets, et al.
British Journal of Cancer|November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeatsJ-F You, O Buhard, M J L Ligtenberg, et al.
Familial Cancer|June 20, 2024
Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case reportL van Riel, C M Kets, L P van Hest, et al.
Journal of Community Genetics|June 7, 2019
Genetic counseling of patients with ovarian carcinoma: acceptance, timing, and psychological wellbeingI Van de Beek, E M A Smets, M A Legdeur, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 8, 2012
Is colorectal surveillance indicated in patients with PTEN mutations?M H Nieuwenhuis, C M Kets, M Murphy-Ryan, et al.
Familial Cancer|January 5, 2019
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohortJ J Bakhuizen, F B Hogervorst, M E Velthuizen, et al.
Journal of the National Cancer Institute|March 20, 2015
Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reductionB A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, et al.
Clinical Genetics|January 17, 2013
MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype studyP Makrythanasis, B W van Bon, M Steehouwer, et al.
Pageof 2